Target intelligence / Profile preview

UDP-glucose:glycoprotein glucosyltransferase 1 (UGGT1)

Target
UGGT1
Molecular classification
Enzyme, Glycosyltransferase, Endoplasmic reticulum chaperone system component
01

Overview

UDP-glucose:glycoprotein glucosyltransferase 1 (UGGT1) is a soluble enzyme resident in the endoplasmic reticulum (ER) that acts as a folding sensor in the glycoprotein quality control system. It recognizes misfolded or incompletely folded glycoproteins and catalyzes the transfer of a glucose residue from UDP-glucose to specific N-glycans on these proteins. This reglucosylation tags the glycoprotein for further interaction with ER lectin chaperones (calnexin and calreticulin), facilitating ensuing cycles of folding or targeting for degradation if refolding fails. UGGT1 is essential for cellular proteostasis, impacting diseases involving protein misfolding (e.g., some storage and neurodegenerative diseases) and the proper function of antigen presentation pathways (such as MHC class I peptide loading). In mammals, two isoforms exist (UGGT1 and UGGT2), with UGGT1 predominating as the key regulator for complex and plasma membrane-bound glycoproteins. Deficiency or dysfunction of UGGT1 can impair glycoprotein maturation, solubility, and ER stress responses, underlying its importance as an ER quality control checkpoint enzyme.

Other names
UDP-glucose glycoprotein glucosyltransferase 1UGGT1UDP-glucose:glycoprotein glucosyltransferaseUGGTUGT1UGTRhUGT1HUGT1UGCGL1UDP--Glc:glycoprotein glucosyltransferaseUDP-glucose ceramide glucosyltransferase-like 1
02

Mechanism of action

For hypothetical drugs targeting UGGT1, expected mechanisms would include: inhibition of glycoprotein reglucosylation, modulation of ER quality control, or alteration of calnexin/calreticulin chaperone cycling

03

Biological functions

Glycoprotein folding quality controlRecognition and reglucosylation of misfolded glycoproteinsMediation of lectin chaperone binding (calnexin/calreticulin cycle)Endoplasmic reticulum-associated degradation (ERAD) involvementModulates MHC class I antigen presentation
04

Disease associations

Protein misfolding diseases/ER storage diseasesCongenital disorders of glycosylation (gene mutations or loss)Disorders related to impaired protein quality control, potentially neurodegenerative diseases and some cancer types
05

Safety considerations

Targeting UGGT1 could disrupt ER protein quality control, leading to accumulation of misfolded proteins and ER stressPossible risk of impaired folding of essential secretory glycoproteins and subsequent organ system dysfunction
06

Interacting drugs

None specifically identified; as of current data, no approved drugs are known to directly target UGGT1
07

Biomarkers

Currently no established clinical biomarkers for UGGT1 specificallyPotential biomarkers could involve ER stress markers or measures of glycoprotein folding efficiency in research settings

Beyond the preview

Go deeper on UDP-glucose:glycoprotein glucosyltransferase 1 (UGGT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UDP-glucose:glycoprotein glucosyltransferase 1 (UGGT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call